Correlation Between Franklin Street and Cyclacel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Franklin Street and Cyclacel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Franklin Street and Cyclacel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Franklin Street Properties and Cyclacel Pharmaceuticals, you can compare the effects of market volatilities on Franklin Street and Cyclacel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Franklin Street with a short position of Cyclacel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Franklin Street and Cyclacel Pharmaceuticals.
Diversification Opportunities for Franklin Street and Cyclacel Pharmaceuticals
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Franklin and Cyclacel is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Franklin Street Properties and Cyclacel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclacel Pharmaceuticals and Franklin Street is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Franklin Street Properties are associated (or correlated) with Cyclacel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclacel Pharmaceuticals has no effect on the direction of Franklin Street i.e., Franklin Street and Cyclacel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Franklin Street and Cyclacel Pharmaceuticals
Considering the 90-day investment horizon Franklin Street Properties is expected to generate 0.29 times more return on investment than Cyclacel Pharmaceuticals. However, Franklin Street Properties is 3.46 times less risky than Cyclacel Pharmaceuticals. It trades about -0.13 of its potential returns per unit of risk. Cyclacel Pharmaceuticals is currently generating about -0.08 per unit of risk. If you would invest 221.00 in Franklin Street Properties on January 30, 2024 and sell it today you would lose (21.00) from holding Franklin Street Properties or give up 9.5% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Franklin Street Properties vs. Cyclacel Pharmaceuticals
Performance |
Timeline |
Franklin Street Prop |
Cyclacel Pharmaceuticals |
Franklin Street and Cyclacel Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Franklin Street and Cyclacel Pharmaceuticals
The main advantage of trading using opposite Franklin Street and Cyclacel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Franklin Street position performs unexpectedly, Cyclacel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclacel Pharmaceuticals will offset losses from the drop in Cyclacel Pharmaceuticals' long position.The idea behind Franklin Street Properties and Cyclacel Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Cyclacel Pharmaceuticals vs. Eliem Therapeutics | Cyclacel Pharmaceuticals vs. Ikena Oncology | Cyclacel Pharmaceuticals vs. Ovid Therapeutics | Cyclacel Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |